Sean Bohen - 26 Dec 2025 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
President and CEO, Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
26 Dec 2025
Net transactions value
$0
Form type
4
Filing time
30 Dec 2025, 16:05:14 UTC
Previous filing
03 Mar 2025
Next filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bohen Sean President and CEO, Director C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN STREET, SAN FRANCISCO /s/ Shane Kovacs, Attorney-in-Fact 29 Dec 2025 0001831218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Gift $0 -8,500 -3.5% $0.000000 237,650 26 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the gift of common stock to a charitable donor advised fund.
F2 Includes 4,488 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.